Delivery Order SPE2DB22D2206-SPE2DB23FJG23
Award Date 7/19/23
Potential Completion Date 7/20/23
Potential Value $9.9
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $71,370 to Amerisourcebergen Drug Corporation to provide one gram vials of methotrexate. As the prime contractor, Amerisourcebergen will deliver 40 milliliter vials of the chemotherapy drug to a location in Conshohocken, Pennsylvania by August 1, 2023 in fulfillment of the Defense Logistics Agency's requirements. The ordering period is one day, from July 31 through August 1, 2023. Amerisourcebergen Corporation is...
- The Defense Logistics Agency awarded a $19,820 firm fixed price delivery order to Amerisourcebergen Drug Corporation for one gram vials of methotrexate. As the prime contractor, Amerisourcebergen will supply 40 milliliter vials of the chemotherapy drug to support the Defense Logistics Agency's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in early September 2023. The parent company, Amerisourcebergen...
- The Defense Logistics Agency awarded a $9,910 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561607421, methotrexate 1 gram/40 ml vials. Amerisourcebergen Drug Corporation will deliver the product from its facility located in Conshohocken, Pennsylvania by July 27, 2023 in support of the Defense Logistics Agency's medical supply needs. As the prime contractor, Amerisourcebergen Drug Corporation will leverage its extensive distribution network and...
- The Defense Logistics Agency awarded a $9,910 delivery order to Amerisourcebergen Drug Corporation for 4561411247, methotrexate in 1 gram/40 ml vials. The firm fixed price order is for 40 ml vials of the chemotherapy drug to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania. Performance will take place between July 5-6, 2023. As a major provider of pharmaceuticals and medical supplies, Amerisourcebergen often supports DLA's procurement and distribution of such products...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $9,910 to Amerisourcebergen Drug Corporation for the supply of 40 milliliter vials containing 1 gram of methotrexate. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from July 26-27, 2023. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will deliver the chemotherapy drug to the DLA in support of its medical supply...
- The Defense Logistics Agency awarded a $9,910 delivery order to Amerisourcebergen Drug Corporation for the supply of 1 gram/40 ml vials of methotrexate. The firm fixed price order is to provide 40 ml vials of the chemotherapy drug to support Defense Logistics Agency programs. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from August 23rd to August 24th, 2023. No subcontractors or set aside designations were identified. The...
- The Defense Logistics Agency awarded a $9,910 delivery order to Amerisourcebergen Drug Corporation for the supply of 1 gram/40 ml vials of methotrexate. The firm fixed price order is to provide 40 ml vials of the chemotherapy drug to locations in Conshohocken, Pennsylvania, with performance required from June 29-30, 2023. Amerisourcebergen will fulfill the order as the prime contractor, with the Defense Logistics Agency serving as the funding agency. The delivery order was issued against an...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $69,370 to Amerisourcebergen Drug Corporation for the supply of 4561521008 Methotrexate 1 gram/40 ml vials. As the parent company of Amerisourcebergen Drug Corporation, Amerisourcebergen Corporation will perform under the contract from its Conshohocken, Pennsylvania location. The delivery order is associated with DLA's pharmaceutical supply chain and has a period of performance from July 17-18, 2023. No set aside...
- The Defense Logistics Agency awarded a $9,910 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 40 milliliter vials of methotrexate at 1 gram per vial. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is for a one day period of July 26-27, 2023. As the DLA supports medical readiness for the Department of Defense, this order for the chemotherapy drug methotrexate is likely to supply military treatment facilities and...
- The Defense Logistics Agency awarded a $9,910 delivery order to Amerisourcebergen Drug Corporation for methotrexate in 1 gram/40 ml vials. The firm fixed price order is for 40 ml vials of the chemotherapy drug to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania and will be completed by August 1, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and supply chain to support the military services and combatant commands....
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FJG23Delivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $9,910 to Amerisourcebergen Drug Corporation for the supply of 4561539910, methotrexate 1 gram/40 ml vials. The delivery order is to provide 40 ml vials of the chemotherapy drug to support Defense Logistics Agency programs. Performance will occur at Amerisourcebergen's facility located in Conshohocken, Pennsylvania over a one day period from July 19, 2023 through July 20, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. No subcontractors or set aside designations were identified in the award information.
Generated 12/23/23, 9:47 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10 | 7/19/23 |